-
Mashup Score: 0
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer - 2 month(s) ago
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer - 3 month(s) ago
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) plus oxaliplatin, fluorouracil, and leucovorin as a first-line treatment for adults living with metastatic pancreatic adenocarcinoma #mPDAC #CheckRare #RareDisease https://t.co/BF5x4I92W6